MD501Y - Method for prophylaxis of postradiation complications in oncologic diseases - Google Patents
Method for prophylaxis of postradiation complications in oncologic diseases Download PDFInfo
- Publication number
- MD501Y MD501Y MDS20110122A MDS20110122A MD501Y MD 501 Y MD501 Y MD 501Y MD S20110122 A MDS20110122 A MD S20110122A MD S20110122 A MDS20110122 A MD S20110122A MD 501 Y MD501 Y MD 501Y
- Authority
- MD
- Moldova
- Prior art keywords
- postradiation
- complications
- prophylaxis
- radiotherapy
- capsule
- Prior art date
Links
- 230000000771 oncological effect Effects 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 2
- 238000001959 radiotherapy Methods 0.000 abstract 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 abstract 1
- XBCXJKGHPABGSD-UHFFFAOYSA-N methyluracil Natural products CN1C=CC(=O)NC1=O XBCXJKGHPABGSD-UHFFFAOYSA-N 0.000 abstract 1
- 230000003439 radiotherapeutic effect Effects 0.000 abstract 1
- 229960003471 retinol Drugs 0.000 abstract 1
- 235000020944 retinol Nutrition 0.000 abstract 1
- 239000011607 retinol Substances 0.000 abstract 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 abstract 1
- 235000010384 tocopherol Nutrition 0.000 abstract 1
- 229960001295 tocopherol Drugs 0.000 abstract 1
- 229930003799 tocopherol Natural products 0.000 abstract 1
- 239000011732 tocopherol Substances 0.000 abstract 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine, namely to radiotherapeutic treatment in oncology.The invention consists in that once a day, immediately after meals, during 15 days from the start of the course of radiotherapy is administered intramuscularly 5 ml of 5% solution of ascorbic acid and perorally one capsule (33000 IU) of retinol, one capsule (0.2 g) of tocopherol and one tablet (0.2 g) of methyluracil. Concomitantly is administered perorally nut kernel oil, one tablespoon (15 ml) twice a day, starting 2…3 days before the start of the course of radiotherapy and then along its entire length.The result is a decrease in the local and general postradiation complications in oncologic patients.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20110122A MD501Z (en) | 2011-06-30 | 2011-06-30 | Method for prophylaxis of postradiation complications in oncologic diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20110122A MD501Z (en) | 2011-06-30 | 2011-06-30 | Method for prophylaxis of postradiation complications in oncologic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD501Y true MD501Y (en) | 2012-04-30 |
| MD501Z MD501Z (en) | 2012-11-30 |
Family
ID=46046410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20110122A MD501Z (en) | 2011-06-30 | 2011-06-30 | Method for prophylaxis of postradiation complications in oncologic diseases |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD501Z (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD2324G2 (en) * | 2003-07-25 | 2004-07-31 | Ион ИЛИЧУК | Metabolism regulating medicament |
| EA201001000A1 (en) * | 2010-04-19 | 2011-10-31 | Алмагуль Тулеуовна Маншарипова | ANTIOXIDANT MEANS OIL BALSAM "JEWELAX" |
-
2011
- 2011-06-30 MD MDS20110122A patent/MD501Z/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD501Z (en) | 2012-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022003072A (en) | Use of pridopidine for treating functional decline. | |
| JO3784B1 (en) | Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer | |
| PH12018500097A1 (en) | Combination of pd-1 antagonist with an egfr inhibitor | |
| EA201591371A1 (en) | Pyridine derivatives as easily degraded inhibitors ROCK | |
| EP4570314A3 (en) | Sacubitril-valsartan dosage regimen for treating chronic systolic heart failure | |
| MX2019007213A (en) | Condensed ring group azacyclobutyl triazole derivative, preparation method therefor and use thereof in medicine. | |
| PH12016501554A1 (en) | Anticancer adjuvant composition containing rip3 expression promoter as active ingredient, method for screening for anticancer adjuvant enhancing sensitivity of anticancer drug by promoting rip3 expression, and method for monitoring sensitivity of anticancer drug | |
| MX2016008027A (en) | Use of laquinimod to delay huntington's disease progression. | |
| MX2016006894A (en) | Combination therapy comprising an inhibitor of jak, cdk and pim. | |
| MX2020007222A (en) | Minocycline for treating inflammatory skin conditions. | |
| MX2014012321A (en) | Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors. | |
| MX2015010594A (en) | Lipobalanced long chain testosterone esters for oral delivery. | |
| MD501Y (en) | Method for prophylaxis of postradiation complications in oncologic diseases | |
| JOP20170044B1 (en) | Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency | |
| MX2019007360A (en) | Azabicyclo-substituted triazole derivative, preparation method thereof, and application of same in medicine. | |
| MD493Y (en) | Method for prophylaxis of postradiation complications in oncological diseases | |
| TW201613600A (en) | Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically | |
| TW201613606A (en) | Therapeutic drug for chronic renal failure | |
| MD596Y (en) | Method for treating the chronic viral hepatitis C | |
| MD482Y (en) | Method for prevention of pelvic organs radiotherapy complications | |
| UA89772U (en) | Method for treating measles in children | |
| UA97257U (en) | Method for prevention and treatment of cardiovascular diseases | |
| RU2013147359A (en) | METHOD FOR CORRECTION OF THE CONDITION OF BONE TISSUE AND PREVENTION OF THE ORIGIN OF FRACTURES IN PATIENTS WITH CARDIOVASCULAR DISEASES | |
| UA71039U (en) | Method for premedication in cancer patients | |
| UA104288U (en) | The method of complex treatment of eczema combined application of antioxidant action |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |